Marie-Claude Fournie-Zaluski

Marie-Claude Fournie-Zaluski publication distribution in Chemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Chemistry in 2026. The highlighted bar marks where Marie-Claude Fournie-Zaluski sits on this spectrum.

Marie-Claude Fournie-Zaluski D-index placement in Chemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Chemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Marie-Claude Fournie-Zaluski sits on this spectrum.

Overview

Best Publications

• The enkephalinase inhibitor thiorphan shows antinociceptive activity in mice

  B P Roques;M C Fournié-Zaluski;E Soroca;J M Lecomte

  855
  Citations

• Identification of metabolic pathways of brain angiotensin II and III using specific aminopeptidase inhibitors: predominant role of angiotensin III in the control of vasopressin release.

  Sylvie Zini;Marie-Claude Fournie-Zaluski;Eric Chauvel;Bernard P. Roques

  449
  Citations

• Viral RNA annealing activities of human immunodeficiency virus type 1 nucleocapsid protein require only peptide domains outside the zinc fingers

  H De Rocquigny;C Gabus;A Vincent;M C Fournié-Zaluski

  383
  Citations

• Analgesic effects of kelatorphan, a new highly potent inhibitor of multiple enkephalin degrading enzymes.

  Marie-Claude Fournie-Zaluski;Pierre Chaillet;Romaine Bouboutou;Annie Coulaud

  250
  Citations

• Autoradiographic comparison of the distribution of the neutral endopeptidase "enkephalinase" and of mu and delta opioid receptors in rat brain

  Gilles Waksman;Edith Hamel;Marie-Claude Fournie-Zaluski;Bernard P. Roques

  248
  Citations

• Inhibiting the breakdown of endogenous opioids and cannabinoids to alleviate pain.

  Bernard P. Roques;Marie-Claude Fournié-Zaluski;Michel Wurm

  247
  Citations

• Δ9-tetrahydrocannabinol releases and facilitates the effects of endogenous enkephalins: reduction in morphine withdrawal syndrome without change in rewarding effect

  Olga Valverde;Florence Noble;Françoise Beslot;Valérie Daugé

  234
  Citations

• Aminopeptidase A inhibitors as potential central antihypertensive agents.

  Annabelle Reaux;Marie Claude Fournie-Zaluski;Christelle David;Sylvie Zini

  226
  Citations

• "Mixed inhibitor-prodrug" as a new approach toward systemically active inhibitors of enkephalin-degrading enzymes.

  Marie Claude Fournie-Zaluski;Pascal Coric;Serge Turcaud;Evelyne Lucas

  216
  Citations

• Conformational behaviour of the active and inactive forms of the nucleocapsid NCp7 of HIV-1 studied by 1H NMR

  N. Morellet;H. de Rocquigny;Y. Mély;N. Jullian

  184
  Citations

• Antidepressant-type effects of endogenous enkephalins protected by systemic RB 101 are mediated by opioid delta and dopamine D1 receptor stimulation.

  Ana Baamonde;Valérie Daugé;Mariano Ruiz-Gayo;Ion Gigel Fulga

  184
  Citations

• Differential Inhibition of Aminopeptidase A and Aminopeptidase N by New .beta.-Amino Thiols

  Eric N. Chauvel;Catherine Llorens-Cortes;Pascale Coric;Sherwin Wilk

  175
  Citations

• First large scale chemical synthesis of the 72 amino acid HIV-1 nucleocapsid protein NCp7 in an active form.

  H. de Rocquigny;D. Ficheux;C. Gabus;M.-C. Fournié-Zaluski

  174
  Citations

• Brain renin-angiotensin system blockade by systemically active aminopeptidase A inhibitors: A potential treatment of salt-dependent hypertension

  Marie-Claude Fournie-Zaluski;Celine Fassot;Bruno Valentin;Dragan Djordjijevic

  173
  Citations

• Selective protection of methionine enkephalin released from brain slices by enkephalinase inhibition.

  G Patey;S De La Baume;JC Schwartz;C Gros

  171
  Citations

• Radioimmunoassay of methionine- and leucine-enkephalins in regions of rat brain and comparison with endorphins estimated by a radioreceptor assay.

  C. Gros;P. Pradelles;C. Rouget;O. Bepoldin

  162
  Citations

• D‐Tyr—Ser—Gly—Phe—Leu—Thr, a highly preferential ligand for δ‐opiate receptors

  Unknown

  158
  Citations

• Characterization of Glu350 as a critical residue involved in the N-terminal amine binding site of aminopeptidase N (EC 3.4.11.2): insights into its mechanism of action.

  Nathalie Luciani;Cynthia Marie-Claire;Emmanuel Ruffet;Ann Beaumont

  155
  Citations

• Aminopeptidase A contributes to the N-terminal truncation of amyloid beta-peptide.

  Jean Sevalle;Audrey Amoyel;Philippe Robert;Marie-Claude Fournié-Zaluski

  149
  Citations

• The μ rather than the δ subtype of opioid receptors appears to be involved in enkephalin-induced analgesia

  Pierre Chaillet;Annie Coulaud;Jean-Marie Zajac;Marie-Claude Fournie-Zaluski

  139
  Citations

• Rational design of enkephalinase inhibitors: substrate specificity of enkephalinase studied from inhibitory potency of various dipeptides.

  Catherine Llorens;Gilles Gacel;Jean-Paul Swerts;Rémi Perdrisot

  134
  Citations

• Structure of the complex between the HIV-1 nucleocapsid protein NCp7 and the single-stranded pentanucleotide d(ACGCC).

  Unknown

  132
  Citations